Modified LDL - Trigger of atherosclerosis and inflammation in the arterial intima

Journal of Internal Medicine

Volumn 247, Issue 3, 2000, Pages 359-370

  Pentikainen M O ^a   Oorni K ^a   Ala Korpela, M ^a   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Atherosclerosis; Inflammation; LDL; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; CHOLESTEROL ESTER; FAT DROPLET; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ARTERY INTIMA; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INFILTRATION; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FOAM CELL; HUMAN; HYDROLYSIS; INFLAMMATION; LIPOPROTEIN METABOLISM; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CHOLESTEROL, LDL; HUMANS; INFLAMMATION; TUNICA INTIMA;

EID: 0034036648     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00655.x     Document Type: Conference Paper

References (97)

1. 1 Virchow R. Phloge und Thrombose im Gefässystem. In: Virchow R, ed. Gesammelte Abhandlungen Zur Wissenschaftlichen Medizin. Berlin: Meidinger Sohn and Co., 1856; 458-63.
2. 2 Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
3. 3 Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095-103.
4. 4 Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-86.
5. 5 Anitschkov N. Experimental arteriosclerosis in animals. In: Cowdry EV, ed. Arteriosclerosis: a Survey of the Problem. New York: Macmillan, 1933; 271-322.
6. 6 Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
7. 7 von Rokitansky C. A Manual of Pathological Anatomy London: The Sydenham Society, 1852.
8. 8 Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52: 223-61.
9. 9 Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
10. 10 Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33.
11. 11 Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. Br Med J 1997; 314: 1778-79.
12. 12 Napoli C, D'armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997; 100: 2680-90.
13. 13 Scanu AM. Structure of human serum lipoproteins. Ann N Y Acad Sci 1972; 195: 390-406.
14. 14 Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341-90.
15. 15 Vasile E, Simionescu M, Simionescu N. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 1983; 96: 1677-89.
16. 16 Kao CH, Chen JK, Yang VC. Ultrastructure and permeability of endothelial cells in branched regions of rat arteries. Atherosclerosis 1994; 105: 97-114.
17. 17 Kao CH, Chen JK, Kuo JS, Yang VC. Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis 1995; 116: 27-41.
18. 18 Brown MS, Kovanen PT, Goldstein JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 1981; 212: 628-35.
19. 19 Reichl D, Postiglione A, Myant NB, Pflug JJ, Milis GL. The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin Sci Mol Med 1973; 49: 419-26.
20. 20 Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-61.
21. 21 Groszek E, Grundy SM. The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. J Chron Dis 1980; 33: 679-84.
22. 22 Smith EB. Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J 1990; 11: 72-81.
23. 23 Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven, 1996; 421-40.
24. 24 Camejo G, Rosengren B, Olson U, Lopez F, Olofson SO, Westerlund C. Molecular basis of the association of arterial proteoglycans with low density lipoproteins: its effect on the structure of the lipoprotein particle. Eur Heart J 1990; 11: 164-73.
25. 25 Nievelstein PFEM, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb 1991; 11: 1795-805.
26. 26 Tamminen M, Mottino G, Qiao JH, Breslow JL, Frank JS. Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 847-53.
27. 27 Völker W, Schmidt A, Buddecke E. Compartmentation and characterization of different proteoglycans in bovine arterial wall. J Histochem Cytohem 1986; 34: 1293-99.
28. 28 Pentikäinen MO, Öörni K, Lassila R, Kovanen PT. The proteoglycan decorin links low density lipoproteins with collagen type I. J Biol Chem 1997; 272: 7633-38.
29. 29 Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv Lipid Res 1982; 19: 1-53.
30. 30 Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL. Indentification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 1998; 101: 2658-64.
31. 31 Borén J, Olin K, O'brien KD et al. Engineering non-atherogenic low density lipoproteins - direct evidence for the 'response-to-retention' hypothesis of atherosclerosis. (Abstract.) Circulation 1998; 98: 1-314.
32. 32 Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79-87.
33. 33 Tertov VV, Bittolo-Bon G, Sobenin IA, Cazzolato G, Orekhov AN, Avogaro P. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Exp Mol Pathol 1995; 62: 166-72.
34. 34 Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation 1996; 94: 1698-704.
35. 35 Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-93.
36. 36 Kol A, Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc Med 1998; 8: 191-99.
37. 37 Amanuma K, Kanaseki T, Ikeuchi Y, Ohkuma S, Takano T. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta of WHHL rabbits. Virchows Arch A 1986; 410: 231-38.
38. 38 Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res 1989; 30: 967-78.
39. 39 Smith EB. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res 1974; 12: 1-49.
40. 40 Guyton JR, Bocan TM, Schifani TA. Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta. Arteriosclerosis 1985; 5: 644-52.
41. 41 Guyton JR, Klemp KF. Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. Am J Pathol 1992; 141: 925-36.
42. 42 Guyton JR, Klemp KF. Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Pathol 1993; 143: 1444-57.
43. 43 Pasquinelli G, Preda P, Vici M et al. Electron microscopy of lipid deposits in human atherosclerosis. Scanning Microsc 1989; 3: 1151-59.
44. 44 Hoff HF, O'neil J, Pepin JM, Cole TB. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur Heart J 1990; 11: 105-15.
45. 45 Pentikäinen MO, Lehtonen EMP, Kovanen PT. Aggregation and fusion of modified low density lipoprotein. J Lipid Res 1996; 37: 2638-49.
46. 46 Pentikäinen MO, Lehtonen EMP, Öörni K et al. Human arterial proteoglycans increase the rate of proteolytic fusion of low density lipoprotein particles. J Biol Chem 1997; 272: 25 283-88.
47. 47 Ala-Korpela M, Pentikäinen MO, Korhonen A, Hevonoja T, Lounila J, Kovanen PT. Detection of low density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy. J Lipid Res 1998; 39: 1705-12.
48. 48 Kokkonen JO, Kovanen PT. Proteolylic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro. J Biol Chem 1989; 264: 10 749-55.
49. 49 Kovanen PT. Role of mast cells in atherosclerosis. Chem Immunol 1995; 62: 132-70.
50. 50 Kovanen PT. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation. Curr Opin Lipidol 1996; 7: 281-86.
51. 51 Piha M, Lindstedt L, Kovanen PT. Fusion of proteolyzed LDL in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry 1995; 34: 10 120-29.
52. 52 Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92: 1084-88.
53. 53 Kaartinen M, Penttilä A, Kovanen PT. Extracellular mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial intima. Functional coupling of exocytosis and phagocytosis in neighboring cells. Arterioscler Thromb Vasc Biol 1995; 15: 2047-54.
54. 54 Kokkonen JO, Kovanen PT. Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules. J Biol Chem 1985; 260: 14 756-63.
55. 55 Ylä-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086-95.
56. 56 Hoff HF, O'neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb 1991; 11: 1209-22.
57. 57 Steinbrecher UP, Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb 1992; 12: 608-25.
58. 58 Torzewski M, Klouche M, Hock J et al. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 1998; 18: 369-78.
59. 59 Schuh J, Fairclough GFJ, Haschemeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 1978; 75: 3173-77.
60. 60 Menschikowski M, Kasper M, Lattke P et al. Secretory group II phospholipase A2 in human atherosclerotic plaques. Atherosclerosis 1995; 118: 173-81.
61. 61 Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg et al. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 1997; 17: 300-309.
62. 62 Romano M, Romano E, Bjorkerud S, Hurt-Camejo E. Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. Arterioscler Thromb Vasc Biol 1998; 18: 519-25.
63. 63 Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tahas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455-64.
64. 64 Schissel SL, Jiang X, Tweedie-Hardman J et al. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 1998; 273: 2738-46.
65. 65 Öörni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingomyelinase induces aggregation and fusion, but phospholipase A(2) only aggregation, of low density lipoprotein (LDL) particles - two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem 1998; 273: 29 127-34.
66. 66 Hakala JK, Öörni K, Ala-Korpela M, Kovanen PT. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. Arterioscler Thromb Vasc Biol 1999; 19: 1276-83.
67. 67 Paananen K, Kovanen PT. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J Biol Chem 1994; 269: 2023-31.
68. 68 Ylä-Herttuala S. Is oxidixed low-density lipoprotein present in vivo? Curr Opin Lipidol 1998; 9: 337-44.
69. 69 Navab M, Berliner JA, Watson AD et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996; 16: 831-42.
70. 70 Calara F, Dimayuga P, Niemann A et al. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol 1998; 18: 884-93.
71. 71 Dobrian A, Mora R, Simionescu M, Simionescu N. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. Biochim Biophys Acta 1993; 1169: 12-24.
72. 72 Kruth HS. Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development. Atherosclerosis 1985; 57: 337-41.
73. 73 Chao FF, Blanchette-Mackie EJ, Chen YJ et al. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. Am J Pathol 1990; 136: 169-79.
74. 74 Guyton JR, Klemp KF. The lipid-rich core region of human atherosclerotic fibrous plaques. Prevalence of small lipid droplets and vesicles by electron microscopy. Am J Pathol 1989; 134: 705-17.
75. 75 Chao FF, Blanchette-Mackie EJ, Tertov VV, Skarlatos SI, Chen YJ, Kruth HS. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem 1992; 267: 4992-98.
76. 76 Bhakdi S, Dorweiler B, Kirchmann R et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995; 182: 1959-71.
77. 77 Kothari HV, Bonner MJ, Miller BF. Cholesterol ester hydrolase in homogenates and lysosomal fractions of human aorta. Biochim Biophys Acta 1970; 202: 325-31.
78. 78 Kothari HV, Miller BF, Kritchevsky D. Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochim Biophys Acta 1973; 296: 446-54.
79. 79 Shamir R, Johnson WJ, Morlock-Fitzpatrick K et al. Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitro. J Clin Invest 1996; 97: 1696-704.
80. 80 Li F, Hui DY. Synthesis and secretion of the pancreatic-type carboxyl ester lipase by human endothelial cells. Biochem J 1998; 329: 675-79.
81. 81 Li F, Hui DY. Modified low density lipoprotein enhances the secretion of bile salt-stimulated cholesterol esterase by human monocyte-macrophages: species-specific difference in macrophage cholesteryl ester hydrolase. J Biol Chem 1997; 272: 28 666-71.
82. 82 Kovanen PT, Kokkonen JO. Modification of low density lipoproteins by secretory granules of rat serosal mast cells. J Biol Chem 1991; 266: 4430-36.
83. 83 Paananen K, Saarinen J, Annila A, Kovanen PT. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans. J Biol Chem 1995; 270: 12 257-62.
84. 84 Öörni K, Pentikäinen MO, Annila A, Kovanen PT. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans: dependence on oxidative modification of the lysine residues. J Biol Chem 1997; 272: 21303-11.
85. 85 Pentikäinen MO, Öörni K, Kovanen PT. Hypochlorite oxidizes lysine residues of heparin-bound LDL, and releases LDL from immobilized heparin. (Abstract.) Atherosclerosis 1997; 134: 216.
86. 86 Gorshkova IN, Menschikowski M, Jaross W. Alterations in the physiochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study. Biochim Biophys Acta 1996; 1300: 103-13.
87. 87 Sartipy P, Johansen B, Camejo G, Rosengren B, Bondjers G, Hurt-Camejo E. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity. J Biol Chem 1996; 271: 26 307-14.
88. 88 Olsson U, Bondjers G, Camejo G. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes 1999; 48: 616-22.
89. 89 Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-87.
90. 90 Hurt-Camejo E, Camejo G. Potential involvement of type II phospholipase A2 in atherosclerosis. Atherosclerosis 1997; 132: 1-8.
91. 91 Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20 963-66.
92. 92 Berliner JA, Territo MC, Sevanian A et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260-66.
93. 93 Klouche M, Gottschling S, Gerl V et al. Atherogenic properties of enzymatically degraded LDL - selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler Thromb Vasc Biol 1998; 18: 1376-85.
94. 94 Tabas I. Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med 1997; 7: 256-63.
95. 95 Klouche M, May AE, Hemmes M et al. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler Thromb Vasc Biol 1999; 19: 784-93.
96. 96 Bhakdi S. Complement and atherogenesis: the unknown connection. Ann Med 1998; 30: 503-507.
97. 97 Schmiedt W, Kinscherf R, Deigner HP et al. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998; 18: 1790-95.